Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 3Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 51Neoplasms 29Prostatic Neoplasms 28Head and Neck Neoplasms 15Lung Neoplasms 14Ovarian Neoplasms 9Pancreatic Neoplasms 8Urinary Bladder Neoplasms 6Sarcoma 6Oropharyngeal Neoplasms 6Hematologic Neoplasms 6Gastrointestinal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Depression 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycystic Ovary Syndrome 4Motor Activity 4Melanoma 4Lymphoma 4Anxiety Disorders 4Stomach Neoplasms 3Pain 3Osteosarcoma 3

Interventions

pembrolizumab 14Nivolumab 11Ipilimumab 10cabozantinib 6Axitinib 6belzutifan 5Radiosurgery 5atezolizumab 4Sunitinib 4palbociclib 3lenvatinib 3Surveys and Questionnaires 3Radiotherapy 3Pluvicto 3Everolimus 3Blood Specimen Collection 3Biopsy 3zimberelimab 2pazopanib 2cemiplimab 2Therapeutics 2Methods 2Magnetic Resonance Spectroscopy 2Irinotecan 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2trebananib 1toripalimab 1tocilizumab 1temsirolimus 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Kidney Neoplasms × Surveys and Questionnaires × 1 year × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT06955910 2026-05-12

Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.

Istituto Oncologico Veneto IRCCS

Active not recruiting
120 enrolled
Genitourinary

Financial Stress, Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms

NCT01888198 2025-07-25

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Memorial Sloan Kettering Cancer Center

Active not recruiting
294 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡